Sageworth Trust’s Cytokinetics CYTK Stock Holding History

Sageworth Trust’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-64	Closed	-$2.25K	–	176
2023 Q1	$2.25K	Hold	64	–	–	﹤0.01%	444
2022 Q4	$3K	Hold	64	–	–	﹤0.01%	303
2022 Q3	$3K	Hold	64	–	–	﹤0.01%	288
2022 Q2	$3K	Hold	64	–	–	﹤0.01%	320
2022 Q1	$2K	Hold	64	–	–	﹤0.01%	309
2021 Q4	$3K	Sell	64 -216	-77%	-$8.34K	﹤0.01%	499
2021 Q3	$10K	Hold	280	–	–	﹤0.01%	548
2021 Q2	$6K	Buy	+280	New	+$6.57K	﹤0.01%	683

Other funds holding CYTK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Sageworth Trust's CYTK Position: Q2 2023 in Review

Sageworth Trust sold out of Cytokinetics (CYTK) in Q2 2023, closing a stake of 64 shares — an estimated $2.25K sold.

Sageworth Trust first reported a position in CYTK in Q2 2021 and held it in 8 quarters. The position peaked at $10K in Q3 2021. 253 funds tracked by Wall St. Rank hold CYTK as of Q2 2023.

Sageworth Trust reported no remaining Cytokinetics position as of Q2 2023 after selling out during the quarter.
Sageworth Trust sold 64 Cytokinetics shares in Q2 2023, an estimated $2.25K.
Sageworth Trust first reported a position in Cytokinetics in Q2 2021 and held it in 8 quarters.
Sageworth Trust's Cytokinetics position peaked at $10K in Q3 2021.
253 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2023.

Based on Sageworth Trust's 13F filing for Q2 2023, filed 26 Jul 2023.